Clinical Trials Directory

Trials / Completed

CompletedNCT02809001

The Effects of Autologous Fat Transfer on Preventing Expanded Skin From Expansion Failure

Status
Completed
Phase
Phase 1 / Phase 2
Study type
Interventional
Enrollment
80 (actual)
Sponsor
Shanghai Jiao Tong University School of Medicine · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to evaluate whether autologous fat grafting is safe and/or effective to prevent expanded skin from expansion failure.

Detailed description

The repair of skin defects is a common problem for reconstructive surgeons.Soft tissue expansion is a widely used technique for the repair of skin defects. Early expansion-related complications such as skin thinning, telangiectasia, and striae may result in expansion failure and ultimately jeopardize final outcome. In the past years, discontinuation of the expansion procedure was the only therapeutic option, when early alarm signs such as semitransparent appearance and telangiectasia of the expanded skin were encountered. We aimed to overcome these complications by therapeutic fat grafting to prevent skin necrosis and enable continuation of the expansion procedure. Patients undergoing soft tissue expansion treatment for resurfacing skin lesions including scars and nevi that required therapeutic intervention due to early complication signs were included in this study. Patients were randomly divided into treatment group using autologous fat grafting and control group with discontinued expansion and expectant management. The treatment group received autologous fat transfer to the expanded skin.

Conditions

Interventions

TypeNameDescription
PROCEDUREFat graftingIn the experimental group, liposuction will be performed and autologous fat graft will be harvest after washing with saline. Patients will receive autologous fat graft transplantation subdermally to expanded skin.

Timeline

Start date
2011-01-01
Primary completion
2016-03-01
Completion
2016-05-01
First posted
2016-06-22
Last updated
2016-06-22

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT02809001. Inclusion in this directory is not an endorsement.